Abiopharma

🔍 Hitchcock Jason (Executive)

Company: Greenlane Holdings, Inc. (GNLN)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 250,000 shares of Stock Option (right to buy) at $0.99 per share (Derivative)
  Date: 2026-03-25 | Code: A | Expires: 2036-02-10 | equity_swap_involved: 0 | shares_owned_after: 250,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: The exercise price equals the closing price of Greenlane Holdings, Inc. (the "Company") Class A Common Stock on February 10, 2026.
• F2: The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board of Directors of the Company on October 14, 2025.
• F3: Options shall vest, unless earlier terminated under the Company's 2019 Equity Incentive Plan, over three (3) years as follows: one-third of the Option shall vest on each of the three (3) anniversaries of February 10, 2026 (the "Vesting Commencement Date"), such that on the third anniversary of the Vesting Commencement Date the Option shall be fully vested provided that Mr. Hitchcock must be an employee in good standing with the Company on such anniversary in order to vest in the applicable portion of the Option.